Abbott Laboratories (ETR:ABL)

Abbott Laboratories Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	187,575	189,494	172,877	179,118	212,232	153,363
Market Cap Growth	19.43%	9.61%	-3.48%	-15.60%	38.39%	12.04%
Enterprise Value	193,283	196,729	180,897	185,558	220,076	164,842
Last Close Price	107.40	107.84	95.91	97.88	116.55	81.41
PE Ratio	15.82	14.69	33.52	27.72	34.28	41.94
PS Ratio	5.11	4.68	4.76	4.39	5.60	5.42
PB Ratio	4.49	4.10	4.92	5.19	6.70	5.68
P/TBV Ratio	11.48	10.96	31.28	55.76	-	-
P/FCF Ratio	-	30.89	37.77	24.53	27.91	32.77
P/OCF Ratio	-	22.92	26.32	19.98	22.92	23.74
EV/Sales Ratio	5.26	4.86	4.99	4.54	5.81	5.83
EV/EBITDA Ratio	19.45	19.01	19.11	16.02	19.64	22.94
EV/EBIT Ratio	27.74	27.17	27.69	21.76	27.19	36.92
EV/FCF Ratio	-	32.07	39.52	25.41	28.94	35.23
Debt / Equity Ratio	0.27	0.32	0.41	0.49	0.53	0.60
Debt / EBITDA Ratio	1.14	1.38	1.47	1.41	1.47	2.18
Debt / FCF Ratio	-	2.40	3.14	2.30	2.23	3.48
Asset Turnover	-	0.54	0.54	0.58	0.58	0.49
Inventory Turnover	-	2.92	2.81	3.37	3.56	3.22
Quick Ratio	-	1.05	1.00	1.06	1.28	1.14
Current Ratio	-	1.67	1.64	1.63	1.85	1.72
Return on Equity (ROE)	-	30.91%	15.11%	19.01%	20.49%	13.91%
Return on Assets (ROA)	-	6.06%	6.11%	7.61%	7.79%	4.86%
Return on Capital (ROIC)	8.76%	7.95%	8.24%	10.34%	10.64%	6.61%
Return on Capital Employed (ROCE)	-	11.10%	12.20%	15.50%	14.80%	9.00%
Earnings Yield	6.32%	6.83%	3.00%	3.62%	2.93%	2.40%
FCF Yield	-	3.24%	2.65%	4.08%	3.58%	3.05%
Dividend Yield	1.96%	2.01%	1.96%	1.84%	1.37%	1.54%
Payout Ratio	-	28.62%	62.13%	47.73%	45.28%	56.95%
Buyback Yield / Dilution	0.07%	0.06%	0.85%	1.40%	-0.17%	-0.28%
Total Shareholder Return	2.02%	2.06%	2.81%	3.23%	1.21%	1.26%

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.